Skip to main content
. 2022 Mar 21;48(4):921–930. doi: 10.1093/schbul/sbac012

Table 1.

Demographic and Clinical Characteristics of Healthy Controls Versus Total Patient Population, and NEET Patients Versus EET Patients

Variable Healthy Control n = 30 All Patients
n = 57
HC vs Patient EET Patient n = 31 NEET Patient n = 26 EET vs NEET
Demographic Data
Sex(Male/Female) 19/11 48/9 x2 = 4.83, P = .028 25/6 23/3 x2 = 0.65, P = .42
Age [M (SD)} 21.57 (3.45) 22.75 (4.28) t(85) = 1.5, P = .14 22.16 (3.92) 23.46 (5.29) t(55) = –1.10, P = .274
ParentalNS-SEC[M (SD)} 3.20(1.42) 3.34 (1.27) t(80) = 0.47, P = .64 3.31 (1.11) 3.42 (1.38) t(51) = 0.47, P = .64
Avg Months to NEET assessment N/A 9.00 (4.38) N/A 8.90 (3.96) 10.04 (4.79) t(55) = 1.79, P = .08
CAST Score 6.13 (0.73) 12.38 (5.94) t(75) = –5.72, P < .01 12.00 (5.88) 12.76(6.09) t(45) = 0.49, P = .625
AUDIT-C 2.77
(2.10)
2.25
(2.63)
t(79) = 0.91
P = .37
2.79 (2.69) 1.61 (2.46) t(49) = 1.61, p=0.12
Smoker (Yes/ No) 0/30 11/46 x2 = 6.62, P = .01 5/26 6/20 x2 = 0.44, P = .51
Clinical Data
DUP [M (SD)] N/A 5.63 (5.74) N/A 5.60 (5.80) 5.67 (5.82) t(53) = –0.04, P = .97
Antipsychotic Defined Daily Dose Equivalents N/A 1.80 (2.81) N/A 1.62 (3.03) 1.79 (2.09) t(55) = –0.06, P = .96
Other Psychotropic Medication (yes/ no) N/A 13/57 N/A 9/31 4/26 x2 = 1.42, P = .22
Baseline SOFAS [M (SD)] 82.92(4.20) 41.04 (12.48) t(77) = 16.30, P < .001 44.38 (14.31) 37.00 (8.45) t(52) = 2.22, P = .03
Follow-up SOFAS [M (SD)] N/A 59.34 (13.70) N/A 67.68 (10.08) 48.37 (9.44) t(42) = 6.47,
P < .001
PANSS-8 Total [M (SD)] 8.0 (0.00) 24.98 (5.76) t(82) = 13.8, P < .01 24.07(4.95) 26.13 (6.57) t(52) = –0.83, P = .41
PANSS-8 Positive [M (SD)} 3.0 (0.00) 12.35 (2.32) t(82) = 18.6, P < .01 12.03 (2.44) 12.75 (2.15) t(52) = –0.94, P = .35
PANSS-8 Negative [M (SD)} 3.0 (0.00) 7.22 (4.17) t(82) = 5.67, P < .01 6.63 (3.76) 7.96 (4.61) t(52) = –0.86, P = .39
CGI- Severity 1.00 5.19 (0.97) t(81) = 23.15, P < .01 5.10 (1.13) 5.29 (0.75) t(52) = –0.85, P = .40

M, Mean; SD, standard deviation; NS-SEC, national statistics socio-economic classification; CAST, Cannabis Abuse Screening Test; DUP, Duration of untreated Psychosis in Months; NEET, Not engaged in employment education or training; EET, Engaged in employment education or training; SOFAS, Social and Occupational Functioning Assessment Score; PANSS-8, Positive and Negative Syndrome Scale—8 Item Scale; PANSS-8 Positive, Positive and Negative Syndrome Scale total score for positive symptom items; PANSS-8 Negative, Positive and Negative Syndrome Scale total score for negative symptom items; CGI-Severity, Clinical Global Impression—Severity.